Endocrinology

Featured Research

First Treatment Protocol for PAPP-A2 Deficiency Emerging In 2015, researchers at Cincinnati Children’s discovered two genetic mutations responsible for a novel growth disorder called PAPP-A2 deficiency. Just a few months later, they turned their attention to developing a treatment protocol for a clinical trial. Now, results from the first year of the experimental therapy are in.